Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-06-14Clinical Trial Update: WB-EMS and Nutrition in Patients With Hematological Malignancies [NA]
A trial update describing the evaluation of whole-body electromyostimulation (WB-EMS) with nutrition in patients with hematologic malignanci…
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Allogeneic Transplant in HIV Patients (BMT CTN 0903) [Phase 2]
Phase 2 clinical trial evaluating allogeneic transplant in HIV-positive patients with leukemia or lymphoma; completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation
A clinical trial investigates whether higher infused autologous lymphocyte counts lead to a stronger antibody response to immunization after…
-
CLINICAL_TRIALS research · 2018-05-22Clinical Trial Update: BeEAC Conditioning Regimen in Malignant Lymphoma Subjects With Indications to Autologous Hematopoietic Stem-cell Transplantation [Phase 2]
Phase 2 trial evaluating BeEAC conditioning regimen in patients with relapsed/refractory malignant lymphoma undergoing autologous hematopoie…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Phase I Trial of PX-478 [Phase 1]
This Phase I trial of PX-478 has completed. The study involved patients with lymphoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: EBUS-TBNA vs Flex 19G EBUS-TBNA [NA]
This clinical trial update reports the completion of a study comparing EBUS-TBNA with Flex 19G EBUS-TBNA.
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients [EARLY_Phase 1]
Early Phase 1 trial results validate an insulin protocol for managing glucocorticoid-induced hyperglycemia in patients with lymphoma and typ…
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation [Phase 1, Phase 2]
A phase 1/2 trial of Clofarabine combined with non-myeloablative allogeneic hematopoietic transplantation was terminated, with results poste…
-
CLINICAL_TRIALS research · 2018-04-24Clinical Trial Update: Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors [Phase 1]
Phase 1 safety and tolerability study of everolimus (RAD001) plus panobinostat (LBH589) in EBV-driven solid tumors, including nasopharyngeal…
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Vorinostat in Children [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating vorinostat in pediatric patients with relapsed solid tumors, lymphoma, or leukemia.
-
CLINICAL_TRIALS other · 2018-04-10Clinical Trial Update: CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma [NA]
Clinical trial update for a CAR-T therapy sponsored by Sinobioway Cell Therapy Co., Ltd. The study aims to evaluate safety and effectiveness…
-
CLINICAL_TRIALS research · 2018-04-06Clinical Trial Update: Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes
Clinical trial update on non-invasive Cerenkov luminescence imaging to visualize lymphoma, leukemia, and metastatic lymph nodes; sponsored b…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating busulfan, cyclophosphamide, and antithymocyte globulin followed by stem cell transplant for hematologic ca…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
The PENELOPE observational study, which examined prophylaxis and treatment of arterial and venous thromboembolism in patients with hematolog…
-
CLINICAL_TRIALS trial_result · 2018-03-16Clinical Trial Update: Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 trial of non-myeloablative HLA-mismatched ex-vivo T-cell depleted stem cell transplantation for hematologic malignancies was termina…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
A Phase 2 study of non-Myeloablative HLA-matched ex-vivo T-cell depleted stem cell transplantation for hematologic malignancies was terminat…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma [NA]
Results from a completed clinical trial examining immune reconstitution after autologous hematopoietic stem cell transplantation in high-ris…
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas [Phase 2]
This document provides an update on a Phase 2 trial evaluating two dosing schedules of perifosine in patients with solid tumors or lymphomas…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 study of NC-4016 in patients with advanced solid tumors or lymphoma has completed enrollment and the trial status is reported as com…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating Y-90 ibritumomab tiuxetan with rituximab for relapsed or refractory diffuse large B-cell non-Hodgkin's lym…
-
CLINICAL_TRIALS withdrawal · 2018-01-19Clinical Trial Update: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma. [Phase 3]
Phase 3 trial of romiplostim for chemotherapy-induced thrombocytopenia in adults with lymphoma was withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial update involving a monoclonal antibody therapy for lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT [Phase 2]
Phase 2 trial evaluating post-transplant cyclophosphamide as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell …
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma [Phase 1]
Phase 1 clinical trial update for DT2219ARL in relapsed or refractory CD19+/CD22+ B-lineage leukemia or lymphoma.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases [Phase 1]
Phase 1 trial evaluating the safety of Umbilical Cord Blood T-Regulatory Cell infusion followed by donor cord blood transplant in patients w…